Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 7351 | 1378 | 23.4 | 68% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
| 233 | 3 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY//ANTIMICROBIAL AGENTS AND CHEMOTHERAPY//FLUOROQUINOLONES | 48717 |
| 451 | 2 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY//ANTIMICROBIAL AGENTS AND CHEMOTHERAPY//CHEMOTHERAPY-TOKYO | 16125 |
| 7351 | 1 | DORIPENEM//ERTAPENEM//MEROPENEM | 1378 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | DORIPENEM | authKW | 1114047 | 6% | 64% | 78 |
| 2 | ERTAPENEM | authKW | 1019612 | 7% | 49% | 94 |
| 3 | MEROPENEM | authKW | 661790 | 9% | 25% | 119 |
| 4 | CARBAPENEMS | authKW | 416238 | 9% | 16% | 121 |
| 5 | IMIPENEM | authKW | 201481 | 4% | 15% | 61 |
| 6 | FAROPENEM | authKW | 155089 | 1% | 50% | 14 |
| 7 | CARBAPENEM ANTIBIOTICS | authKW | 153288 | 1% | 43% | 16 |
| 8 | BIAPENEM | authKW | 133723 | 1% | 46% | 13 |
| 9 | PANIPENEM | authKW | 123088 | 1% | 56% | 10 |
| 10 | IMIPENEM CILASTATIN | authKW | 116404 | 1% | 31% | 17 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Infectious Diseases | 21493 | 37% | 0% | 513 |
| 2 | Microbiology | 20047 | 50% | 0% | 691 |
| 3 | Pharmacology & Pharmacy | 16586 | 63% | 0% | 870 |
| 4 | Chemistry, Analytical | 226 | 7% | 0% | 96 |
| 5 | Immunology | 138 | 7% | 0% | 92 |
| 6 | Biochemical Research Methods | 125 | 4% | 0% | 57 |
| 7 | Medicine, General & Internal | 58 | 5% | 0% | 66 |
| 8 | Chemistry, Medicinal | 52 | 3% | 0% | 36 |
| 9 | Toxicology | 50 | 3% | 0% | 36 |
| 10 | Oncology | 26 | 5% | 0% | 63 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | TANAKA | 44315 | 0% | 100% | 2 |
| 2 | MOL CRYSTALS | 42604 | 0% | 38% | 5 |
| 3 | AIN PHARMACIEZ SHIKAHAMA BRANCH | 22158 | 0% | 100% | 1 |
| 4 | ANALYT METHODS SUPPORT | 22158 | 0% | 100% | 1 |
| 5 | ARZT FUER INNERE MED MIKROBIOL INFEKT SEPIDEMIO | 22158 | 0% | 100% | 1 |
| 6 | BIOSANITARIO INVEST EXPT | 22158 | 0% | 100% | 1 |
| 7 | BRSITOL ANTIMICROBIAL EVALUAT | 22158 | 0% | 100% | 1 |
| 8 | CHILDRENS HOSP HLTH SCI | 22158 | 0% | 100% | 1 |
| 9 | CLIN DEV CHUO KU | 22158 | 0% | 100% | 1 |
| 10 | CLIN MEGURO KU | 22158 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 110347 | 18% | 2% | 249 |
| 2 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 45837 | 16% | 1% | 221 |
| 3 | JOURNAL OF CHEMOTHERAPY | 8014 | 2% | 1% | 30 |
| 4 | CHEMOTHERAPY | 7823 | 2% | 1% | 30 |
| 5 | INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 7460 | 3% | 1% | 36 |
| 6 | DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 3957 | 2% | 1% | 31 |
| 7 | EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES | 3565 | 2% | 1% | 32 |
| 8 | REVIEWS OF INFECTIOUS DISEASES | 3122 | 1% | 1% | 19 |
| 9 | COMPLICATIONS IN SURGERY | 2951 | 0% | 7% | 2 |
| 10 | INFECTION | 2822 | 2% | 1% | 22 |
Author Key Words |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | DORIPENEM | 1114047 | 6% | 64% | 78 | Search DORIPENEM | Search DORIPENEM |
| 2 | ERTAPENEM | 1019612 | 7% | 49% | 94 | Search ERTAPENEM | Search ERTAPENEM |
| 3 | MEROPENEM | 661790 | 9% | 25% | 119 | Search MEROPENEM | Search MEROPENEM |
| 4 | CARBAPENEMS | 416238 | 9% | 16% | 121 | Search CARBAPENEMS | Search CARBAPENEMS |
| 5 | IMIPENEM | 201481 | 4% | 15% | 61 | Search IMIPENEM | Search IMIPENEM |
| 6 | FAROPENEM | 155089 | 1% | 50% | 14 | Search FAROPENEM | Search FAROPENEM |
| 7 | CARBAPENEM ANTIBIOTICS | 153288 | 1% | 43% | 16 | Search CARBAPENEM+ANTIBIOTICS | Search CARBAPENEM+ANTIBIOTICS |
| 8 | BIAPENEM | 133723 | 1% | 46% | 13 | Search BIAPENEM | Search BIAPENEM |
| 9 | PANIPENEM | 123088 | 1% | 56% | 10 | Search PANIPENEM | Search PANIPENEM |
| 10 | IMIPENEM CILASTATIN | 116404 | 1% | 31% | 17 | Search IMIPENEM+CILASTATIN | Search IMIPENEM+CILASTATIN |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | BREILH, D , TEXIER-MAUGEIN, J , ALLAOUCHICHE, B , SAUX, MC , BOSELLI, E , (2013) CARBAPENEMS.JOURNAL OF CHEMOTHERAPY. VOL. 25. ISSUE 1. P. 1-17 | 90 | 63% | 14 |
| 2 | ZHANEL, GG , WIEBE, R , DILAY, L , THOMSON, K , RUBINSTEIN, E , HOBAN, DJ , NOREDDIN, AM , KARLOWSKY, JA , (2007) COMPARATIVE REVIEW OF THE CARBAPENEMS.DRUGS. VOL. 67. ISSUE 7. P. 1027-1052 | 71 | 73% | 191 |
| 3 | CIELECKA-PIONTEK, J , MICHALSKA, K , ZALEWSKI, P , ZASADA, S , (2012) COMPARATIVE REVIEW OF ANALYTICAL TECHNIQUES FOR DETERMINATION OF CARBAPENEMS.CURRENT ANALYTICAL CHEMISTRY. VOL. 8. ISSUE 1. P. 91-115 | 80 | 72% | 5 |
| 4 | FISH, DN , SINGLETARY, TJ , (1997) MEROPENEM, A NEW CARBAPENEM ANTIBIOTIC.PHARMACOTHERAPY. VOL. 17. ISSUE 4. P. 644-669 | 89 | 71% | 24 |
| 5 | MATTHEWS, SJ , LANCASTER, JW , (2009) DORIPENEM MONOHYDRATE, A BROAD-SPECTRUM CARBAPENEM ANTIBIOTIC.CLINICAL THERAPEUTICS. VOL. 31. ISSUE 1. P. 42-63 | 51 | 76% | 38 |
| 6 | BURKHARDT, O , DERENDORF, H , WELTE, T , (2007) ERTAPENEM: THE NEW CARBAPENEM 5 YEARS AFTER FIRST FDA LICENSING FOR CLINICAL PRACTICE.EXPERT OPINION ON PHARMACOTHERAPY. VOL. 8. ISSUE 2. P. 237-256 | 60 | 71% | 25 |
| 7 | KEATING, GM , PERRY, CM , (2005) ERTAPENEM - A REVIEW OF ITS USE IN THE TREATMENT OF BACTERIAL INFECTIONS.DRUGS. VOL. 65. ISSUE 15. P. 2151-2178 | 63 | 68% | 51 |
| 8 | EL-GAMAL, MI , OH, CH , (2010) CURRENT STATUS OF CARBAPENEM ANTIBIOTICS.CURRENT TOPICS IN MEDICINAL CHEMISTRY. VOL. 10. ISSUE 18. P. 1882-1897 | 71 | 54% | 13 |
| 9 | CIELECKA-PIONTEK, J , MICHALSKA, K , ZALEWSKI, P , JELINSKA, A , (2011) RECENT ADVANCES IN STABILITY STUDIES OF CARBAPENEMS.CURRENT PHARMACEUTICAL ANALYSIS. VOL. 7. ISSUE 4. P. 213-227 | 46 | 81% | 7 |
| 10 | MILLER, AD , BALL, AM , BOOKSTAVER, PB , DORNBLASER, EK , BENNETT, CL , (2011) EPILEPTOGENIC POTENTIAL OF CARBAPENEM AGENTS: MECHANISM OF ACTION, SEIZURE RATES, AND CLINICAL CONSIDERATIONS.PHARMACOTHERAPY. VOL. 31. ISSUE 4. P. 408 -423 | 58 | 60% | 20 |
Classes with closest relation at Level 1 |